December 22, 2020

AARDA Statement on CMS Decision to Delay Copay Assistance Rule

AARDA Statement on CMS Decision to Delay Copay Assistance Rule Washington, D.C. (Tuesday, December 22, 2020) — Autoimmune patients welcome the Administration’s decision to delay implementation […]
December 17, 2020

AARDA Signs on to ACCC Letter on NBPP 2022

AARDA Signs on to ACCC Letter on NBPP 2022 AARDA signed on to the All Copays Count Coalition’s Sign-On Letter regarding the HHS Notice of Benefit […]
December 2, 2020

AARDA Joins CV19 Educate America Campaign

AARDA Joins CV19 Educate America Campaign AARDA has joined the national CV19 Educate America Campaign to help inform the public about CV19 CheckUp, an online system […]
November 24, 2020

AARDA Most Favored Nation Model (MFN) Statement of Concern

AARDA Most Favored Nation Model (MFN) Statement of Concern The American Autoimmune Related Diseases Association (AARDA) is greatly concerned that the Most Favored Nation Model (MFN) […]
November 24, 2020

INSIGHT: Tim Walbert, CEO of Horizon Therapeutics

INSIGHT: Tim Walbert, CEO of Horizon Therapeutics   Our series, INSIGHT: Conversations with Thought Leaders, has a new interview with the CEO of Horizon Therapeutics. On […]
November 18, 2020

Thyroid Eye Disease (TED) Awareness Week

November 2, 2020

National Briefing on COVID-19 & Autoimmune Disease: Research Insights, Treatment & Prevention

October 6, 2020

National Webinar on Managing Stress and Promoting Well-Being: Living With Chronic Pain

September 3, 2020

Innovation in Pain Management: 5 Takeaways from a Survey of Chronic Pain Patients

AARDA received 450 individual responses to the Patient Experiences with Chronic Pain Survey this June. The findings illustrate the key needs of patients in pain and […]